GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Front Immunol. 2022 Mar 8;13:857308. doi: 10.3389/fimmu.2022.857308. eCollection 2022.
Front Immunol. 2022.
PMID: 35345673
Free PMC article.